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Background: Clinical trials have not clearly identified specific therapies that improve outcomes for patients hospitalized with heart failure 
(HF) and preserved ejection fraction (HFpEF). This uncertainty is likely to result in variation in care for HFpEF patients in US hospitals.
methods: We identified patients ≥18 years admitted with HFpEF (ICD-9-CM diagnosis codes 428.30-428.33) between January 2009 and 
June 2012 to hospitals participating in the PREMIER, Inc. data warehouse. Only the first admission was included for each patient. We 
computed the percent of patients at each hospital receiving each therapy and evaluated the percentile distributions to describe hospital-
level variation in use.
results: We examined 56,090 hospitalizations for HFpEF at 355 hospitals. Figure 1 shows hospital-rates of the most commonly used 
diagnostic tests: echocardiogram (66.6%, IQR 61.1-73.0%) and stress test (5.8%, IQR 2.8-10.0%). The use of IV diuretics was high with 
less variation (96.6%, IQR 94.5- 98.0%); while other medical therapies showed more variation across hospitals. Non-invasive ventilation 
use (16.3%, IQR 10.9-20.8%) was higher than invasive ventilation (2.8%, IQR 1.2-5.7%). Median length of stay was 4 days (IQR 4-5 days) 
and in-hospital mortality was 2.29% (IQR=1.30-3.45%)
conclusion:  Substantial variation exists among hospitals in the use of tests, treatments and in-hospital mortality for HFpEF. Further 
research is needed to identify hospital practices associated with better outcomes.
 
